Minerva ginecologica 2013-06-01

Endogenous sex hormones are not associated with subclinical atherosclerosis in menopausal women.

D Celestino Catão Da Silva, A Nogueira De Almeida Vasconcelos, J Cleto Maria Cerqueira, D De Oliveira Cipriano Torres, A C Oliveira Dos Santos, H De Lima Ferreira Fernandes Costa, L O Bregieiro Fernandes Costa

Index: Minerva Ginecol. 65(3) , 297-302, (2013)

Full Text: HTML

Abstract

The aim of this paper was to compare the carotid intima-media thickness (IMT) in pre- and postmenopausal women and to evaluate the association between endogenous sex hormones, body fat distribution, and insulin resistance and the IMT.This cross-sectional study included 145 women aged 45-65 yr, comprising 56 premenopausal (FSH<20IU/mL and regular menstrual cycles) and 89 postmenopausal (FSH>40IU/ml and amenorrheic). All patients were evaluated for lipid profile, estradiol and testosterone, insulin ratio (G/I), HOMA-IR, and ultrasound measurement of IMT. Each variable was assessed for correlation with IMT using the univariate model.No difference was observed in IMT between pre- and postmenopausal women. A positive and statistically significant correlation was found between IMT and FSH levels (rs=0.21, P<0.009) and HOMA (rs=0.16, P<0.04). A positive and statistically significant correlation was observed between testosterone and waist (rs=0.3, P<0.04). No correlation was found between IMT and time of menopause (r=0.02, P=0.19).Estradiol and testosterone are not associated with subclinical atherosclerosis in menopausal women. A positive correlation between IMT and FSH may reflect an association between low estrogen and IMT. Abdominal fat can be an important link between androgenic levels and cardiovascular risk.


Related Compounds

  • beta-Estradiol
  • Follicle-stimulati...
  • ESTRADIOL HE...

Related Articles:

Inducible, tightly regulated and growth condition-independent transcription factor in Saccharomyces cerevisiae.

2014-01-01

[Nucleic Acids Res. 42(17) , e130, (2014)]

A precisely substituted benzopyran targets androgen refractory prostate cancer cells through selective modulation of estrogen receptors.

2015-03-15

[Toxicol. Appl. Pharmacol. 283(3) , 187-97, (2015)]

Alpha-fetoprotein, identified as a novel marker for the antioxidant effect of placental extract, exhibits synergistic antioxidant activity in the presence of estradiol.

2014-01-01

[PLoS ONE 9(6) , e99421, (2014)]

Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86.

2014-01-01

[BMC Cancer 14 , 853, (2014)]

Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.

2015-04-01

[Cancer Res. 75(7) , 1457-69, (2015)]

More Articles...